News
In a study known as CROWNS-2 published in JAMA, the researchers randomly assigned 180 adults with CRSwNP to stapokibart (300 ...
Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks to the ...
Kids are back in school and that means flu season is right around the corner - but now, families have the option to give ...
9h
Inquirer Business on MSNDTI, AstraZeneca to develop Pharma Innovation Hub
MANILA, Philippines - The government is partnering with the local subsidiary of multinational pharmaceutical company ...
FluMist Home is an influenza vaccine that’s administered via nasal spray, which means no needles and no waiting in line at ...
The Department of Trade and Industry, through the Philippine Economic Zone Authority (PEZA), sealed a partnership with ...
The Philippine Economic Zone Authority (Peza) has sealed a deal with AstraZeneca Pharmaceuticals (Phils.) to establish the country’s first pharma innovation hub, a flagship project aimed at boosting ...
Celldex has stopped development of barzolvolimab in eosinophilic esophagitis (EoE) despite meeting its primary endpoint in a ...
22h
BusinessWorld on MSNAstraZeneca to build Philippines’ first pharma innovation hub
THE Department of Trade and Industry (DTI) said it tapped AstraZeneca Pharmaceuticals to help build the Philippines’ first pharma innovation hub. The hub stems from a memorandum of understanding (MoU) ...
Today’s announcement (August 20) on draft guidelines from the UK’s National Institute for Health and Care Excellence (NICE) ...
Investors who buy foreign stocks often don’t own the shares directly — they hold American Depositary Receipts, or ADRs. Yahoo ...
STOCKHOLM, SE / ACCESS Newswire / August 20, 2025 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results